Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (301-310 of 1,859) with videos related to

Pageof 186
Sort By:
Cardiology in Review|June 20, 2025
Vericiguat, a Soluble Guanylate Cyclase Stimulator Approved for Heart Failure TreatmentMohammed Kallash, William H Frishman
Cardiology in Review|October 8, 2010
Liver x receptors: a potential therapeutic target for modulating the atherosclerotic processNeil Parikh, William H Frishman
Journal of Clinical Pharmacology|May 20, 1998
Innovative drug treatments for viral and autoimmune myocarditisS Anandasabapathy, W H Frishman
Cardiology in Review|May 9, 2023
Teplizumab Therapy to Delay the Onset of Type 1 DiabetesJoel Novograd, William H Frishman
Cardiology in Review|October 7, 2017
Westchester Medical Center and Its Health Care System: One Hundred Years (1917-2017) of Dedicated Service to Community, Country, and CardiologyWilliam H Frishman, John Savino
Cardiology in Review|December 15, 2004
Protein kinase C in cardiac disease and as a potential therapeutic targetStephen Murphy, William H Frishman
Neurosurgery|June 1, 1980
Neurogenic hypertension related to vascular compression of the lateral medullaJ M Fein, W Frishman
Drugs|June 1, 1990
Clinical use of beta-adrenoceptor blockade in systemic hypertensionJ Nadelmann, W H Frishman
Cardiology in Review|June 20, 2008
Statin-drug interactions: not a class effectWilliam H Frishman, John Horn
The Medical Clinics of North America|January 1, 1988
Antianginal drug therapy for silent myocardial ischemiaW H Frishman, M Teicher
Pageof 186

Showing results (301-310 of 1,859) with videos related to

Sort By:
Pageof 186
Cardiology in Review|June 20, 2025
Vericiguat, a Soluble Guanylate Cyclase Stimulator Approved for Heart Failure TreatmentMohammed Kallash, William H Frishman
Cardiology in Review|October 8, 2010
Liver x receptors: a potential therapeutic target for modulating the atherosclerotic processNeil Parikh, William H Frishman
Journal of Clinical Pharmacology|May 20, 1998
Innovative drug treatments for viral and autoimmune myocarditisS Anandasabapathy, W H Frishman
Cardiology in Review|May 9, 2023
Teplizumab Therapy to Delay the Onset of Type 1 DiabetesJoel Novograd, William H Frishman
Cardiology in Review|October 7, 2017
Westchester Medical Center and Its Health Care System: One Hundred Years (1917-2017) of Dedicated Service to Community, Country, and CardiologyWilliam H Frishman, John Savino
Cardiology in Review|December 15, 2004
Protein kinase C in cardiac disease and as a potential therapeutic targetStephen Murphy, William H Frishman
Neurosurgery|June 1, 1980
Neurogenic hypertension related to vascular compression of the lateral medullaJ M Fein, W Frishman
Drugs|June 1, 1990
Clinical use of beta-adrenoceptor blockade in systemic hypertensionJ Nadelmann, W H Frishman
Cardiology in Review|June 20, 2008
Statin-drug interactions: not a class effectWilliam H Frishman, John Horn
The Medical Clinics of North America|January 1, 1988
Antianginal drug therapy for silent myocardial ischemiaW H Frishman, M Teicher
Pageof 186